Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14672
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTep-Areenan P.
dc.contributor.authorSawasdee P.
dc.contributor.authorRandall M.
dc.date.accessioned2021-04-05T03:36:22Z-
dc.date.available2021-04-05T03:36:22Z-
dc.date.issued2010
dc.identifier.issn0951418X
dc.identifier.other2-s2.0-78649435662
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14672-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-78649435662&doi=10.1002%2fptr.3164&partnerID=40&md5=dafc575a3aa8fdd8c37ac5dee819df86
dc.description.abstractThe present study investigated the vascular effects of 5,7-dimethoxyflavone (DMF), isolated from the rhizomes of Kaempferia parviflora (KP), on rat isolated aortic rings and its possible mechanisms. DMF (1-100 μm) caused concentration-dependent relaxations in aortic rings precontracted with methoxamine. This effect was significantly reduced by removal of the endothelium, and after pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, 300 μm), indomethacin (10 μm) and 1H-[1,2,4]oxadiazolo-[4, 3-a]quinoxalin-1-one (ODQ, 10 μm), but not 9-(tetrahydro-2-furanyl)-9H- purine-6-amine (SQ22536, 100 μm). Relaxant responses to DMF were significantly inhibited by high KCl (60 mm) in both endothelium-intact and -denuded rings. In addition, the relaxations to DMF were significantly reduced by pretreatment with tetraethylammonium (TEA, 5 mm), glibenclamide (10 μm), 4-aminopyridine (1 mm) or barium chloride (10 μm). Preincubation with DMF (10 and 100 μm) for 30 min significantly inhibited the contractile responses to CaCl2 in a Ca2+-free, high K+ buffer. The present study demonstrated that DMF causes endothelium-dependent relaxation that is partly mediated by NO-cGMP and cyclooxygenase pathways. Interestingly, DMF-induced responses are mainly due to increasing K+ efflux, and inhibition of Ca2+ influx from the extracellular space. The vasodilator effects of DMF provide experimental support for the potential use of KP as a medical plant in the treatment of cardiovascular diseases. © 2010 John Wiley & Sons, Ltd.
dc.subject1h 1,2,4 oxadiazolo[4,3 a]quinoxalin 1 one
dc.subject4 aminopyridine
dc.subject5,7 dimethoxyflavone
dc.subjectbarium chloride
dc.subjectbuffer
dc.subjectcalcium chloride
dc.subjectflavone
dc.subjectglibenclamide
dc.subjectindometacin
dc.subjectmethoxamine
dc.subjectn(g) nitroarginine methyl ester
dc.subjectpotassium chloride
dc.subjecttetrylammonium
dc.subjectunclassified drug
dc.subjectanimal cell
dc.subjectanimal experiment
dc.subjectarticle
dc.subjectcalcium transport
dc.subjectcardiovascular disease
dc.subjectcontrolled study
dc.subjectendothelium
dc.subjectextracellular space
dc.subjectmale
dc.subjectmedicinal plant
dc.subjectnonhuman
dc.subjectpotassium transport
dc.subjectrat
dc.subjectrhizome
dc.subjectvascular ring
dc.subjectvasodilatation
dc.subjectAnimals
dc.subjectAorta
dc.subjectCalcium
dc.subjectCyclic GMP
dc.subjectFlavonoids
dc.subjectMale
dc.subjectNitric Oxide
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectRhizome
dc.subjectVasodilation
dc.subjectZingiberaceae
dc.subjectKaempferia parviflora
dc.subjectRattus
dc.titlePossible mechanisms of vasorelaxation for 5,7-dimethoxyflavone from Kaempferia parviflora in the rat aorta
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationPhytotherapy Research. Vol 24, No.10 (2010), p.1520-1525
dc.identifier.doi10.1002/ptr.3164
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.